載入...
Combined Therapy With a Calcium Channel Blocker and an Angiotensin II Type 1 Receptor Blocker
Fixed‐dosed combination regimens consisting of a calcium channel blocker and an angiotensin II type 1 receptor blocker represent a new addition to the available antihypertensive treatment options. Clinical trials demonstrate that both the dihydropyridine calcium channel blocker amlodipine and angiot...
Na minha lista:
| 發表在: | J Clin Hypertens (Greenwich) |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Blackwell Publishing Inc
2008
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8110040/ https://ncbi.nlm.nih.gov/pubmed/18174781 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2007.08029.x |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|